Valneva SE ADR
Price & Volume
Stats
See more52W Range | $5.40-$14.49 |
Market Cap | $468M |
Shares Short | 55,211 |
Financials
See moreRevenue (12 Mos) | $156.4M |
Revenue Growth (YoY) | -5.4% |
Gross Profit (12 Mos) | -$68M |
Diluted EPS | -$0.52 |
News
See moreYahoo Finance • 8 months ago
Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript
Yahoo Finance • 10 months ago
16 Most Promising Long-Term Stocks According to Analysts
Yahoo Finance • 12 months ago
Valneva SE (NASDAQ:VALN) Q3 2023 Earnings Call Transcript
Yahoo Finance • 2 years ago
Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate
About
CEO | Mr. Thomas Lingelbach |
Address | 6 rue Alain Bombard, Saint-Herblain, France, 44800 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 700 |
